Sanofi India Ltd - 500674 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31St March 2021
Pursuant to Regulation 40 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith Certificate of M/s. Makarand M. Joshi & Co., Company Secretaries for the half year ended 31st March 2021. Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed copies of the Notice of the Board Meeting of the Company published today, in newspapers, Business Standard and Sakal. Sanofi India Ltd - 500674 - Board Meeting Intimation for Meeting Of Board Of Directors To Be Held On 27Th April 2021
Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/04/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company will be held on Tuesday, 27th April 2021; inter alia to consider the unaudited financial results for the quarter ended 31st March 2021 (Q1). Sanofi India Ltd - 500674 - Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1230 Name of the Signatory :- GIRISH TEKCHANDANIDesignation :- Company Secretary and Compliance Officer Sanofi India Ltd - 500674 - Compliances - Compliance Certificate For The Period Ended 31St March 2021
Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the compliance certificate for the period 1st October 2020 to 31st March 2021. Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Dividend Updates
Please find enclosed copy of the letter on - ''Communication of deduction of tax at source on Dividend'' sent to the shareholders on 6th April 2021 through email who have registered their email ID with the Company / Depositories. The said communication is also being made available on the website on the Company at www.sanofiindialtd.com. Sanofi India Ltd - 500674 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company has provided the enclosed certificate for the quarter ended 31st March 2021 under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed copies of the Notice of the Annual General Meeting and E-voting information of the Company published today, in newspapers, Business Standard and Sakal. Sanofi India Ltd - 500674 - Reg. 34 (1) Annual Report
Pursuant to Regulation 34 (1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the Annual Report for the financial year ended 31st December 2020 along with the Notice of the 65th Annual General Meeting (AGM) which is scheduled to be held on 27th April 2021 through video conferencing (VC) facility for your information and records. The Annual Report is sent to the members who have registered their email ID with the Company/Depositories. The members can also access the Annual Report on the website of the Company - www.sanofiindialtd.com. Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has issued duplicate share certificates in lieu of the original share certificates reported lost/misplaced, details of which are enclosed.